Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982761priorityCriticalpatent/ECSP982761A/en
Publication of ECSP982761ApublicationCriticalpatent/ECSP982761A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
El invento se relaciona con composiciones farmacéuticas orales útiles en el tratamiento de ciclooxigenasa-2-, condiciones mediana y/o desórdenes que comprende un agente activo de celecoxib en una cantidad desde aproximadamente 10 mg a aproximadamente 1000mg y uno o más materiales portadores.The invention relates to oral pharmaceutical compositions useful in the treatment of cyclooxygenase-2, median conditions and / or disorders comprising a celecoxib active agent in an amount of from about 10mg to about 1000mg and one or more carrier materials.
METHOD AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF PAIN AND INFLAMMATION WITH A SELECTIVE INHIBITOR OF CYCLLOXYGENASA-2 AND CONDROITIN SULFATE.